Jaren Landen - 18 Nov 2024 Form 3 Insider Report for CASSAVA SCIENCES INC (SAVA)

Role
Chief Clinical Dev. Officer
Signature
/s/ Eric J. Schoen by Power of Attorney
Issuer symbol
SAVA
Transactions as of
18 Nov 2024
Net transactions value
$0
Form type
3
Filing time
20 Nov 2024, 16:37:14 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SAVA Stock Option (Right to Buy) 18 Nov 2024 Common Stock 15,000 $26.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on September 16, 2025

Remarks:

Exhibit List – Ex. 24 – Power of Attorney.